Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Our experiences with measurement of new potential biomarkers in the diagnosis of latent forms of myocardial ischemia

D. Stejskal, B. Lacnak, M. Karpisek, M. Kaminek

. 2006 ; 150 (2) : 239-244.

Language English Country Czech Republic

Document type Journal Article

BACKGROUND: The need for a laboratory marker of myocardial ischemia has been alluded to for at least the last decade. AIM: The aim of this study was to evaluate the diagnostic importance of the myosin light chain-1 (MLC-1), clusterin and Reg-Ialpha in patients with suspected myocardial ischemia. METHODS: A group of 176 at high-risk for myocardial ischemia subjects was evaluated and divided into two subgroups using myocardial SPECT (Single Photon Emission Computed Tomography) - individuals with and without signs of myocardial ischemia. Laboratory markers in venous blood were repeatedly examined in all subjects: a) immediately prior to SPECT: C-reactive protein, Haemoglobin, Hematocrite, Lactate, MLC-1, Clusterin, Reg-Ialpha b) at subjective maximum: Hb, Htc, lactate, MLC-1, Clusterin, Reg-Ialpha c) 30 min after stress levels reached their peak: MLC-1, Clusterin, Reg-Ialpha and d) 60 min after peak stress levels: MLC-1, Clusterin, Reg-Ialpha. RESULTS: Patients were divided into subgroups according to their positive and negative SPECT results (positive: n = 37; negative: n = 139). MLC-1 values were different for all 4 blood collections. An increase in MLC-1 > 2.2 mg/l showed 64 % sensitivity and 88 % specificity for the diagnosed presence of myocardial ischemia (AUC 0.81; LR+ 5.9; PPV+ 68 % and NPV- 87 %). There was no significant difference between the groups in terms of Clusterin and Reg-Ialpha for any of the sampling periods. CONCLUSIONS: High diagnostic efficacy of detectable MLC-1 was shown for the diagnosis of latent myocardial ischemia. Measurement of serum Clusterin or Reg-Ialpha did not sufficient for the diagnosis of latent myocardial ischemia.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13003672
003      
CZ-PrNML
005      
20130213090509.0
007      
ta
008      
130128s2006 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2006.034 $2 doi
035    __
$a (PubMed)17426785
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Stejskal, David, $d 1967- $7 xx0042302 $u Department of Laboratory Medicine and Internal Department, Sternberk Hospital
245    10
$a Our experiences with measurement of new potential biomarkers in the diagnosis of latent forms of myocardial ischemia / $c D. Stejskal, B. Lacnak, M. Karpisek, M. Kaminek
520    9_
$a BACKGROUND: The need for a laboratory marker of myocardial ischemia has been alluded to for at least the last decade. AIM: The aim of this study was to evaluate the diagnostic importance of the myosin light chain-1 (MLC-1), clusterin and Reg-Ialpha in patients with suspected myocardial ischemia. METHODS: A group of 176 at high-risk for myocardial ischemia subjects was evaluated and divided into two subgroups using myocardial SPECT (Single Photon Emission Computed Tomography) - individuals with and without signs of myocardial ischemia. Laboratory markers in venous blood were repeatedly examined in all subjects: a) immediately prior to SPECT: C-reactive protein, Haemoglobin, Hematocrite, Lactate, MLC-1, Clusterin, Reg-Ialpha b) at subjective maximum: Hb, Htc, lactate, MLC-1, Clusterin, Reg-Ialpha c) 30 min after stress levels reached their peak: MLC-1, Clusterin, Reg-Ialpha and d) 60 min after peak stress levels: MLC-1, Clusterin, Reg-Ialpha. RESULTS: Patients were divided into subgroups according to their positive and negative SPECT results (positive: n = 37; negative: n = 139). MLC-1 values were different for all 4 blood collections. An increase in MLC-1 > 2.2 mg/l showed 64 % sensitivity and 88 % specificity for the diagnosed presence of myocardial ischemia (AUC 0.81; LR+ 5.9; PPV+ 68 % and NPV- 87 %). There was no significant difference between the groups in terms of Clusterin and Reg-Ialpha for any of the sampling periods. CONCLUSIONS: High diagnostic efficacy of detectable MLC-1 was shown for the diagnosis of latent myocardial ischemia. Measurement of serum Clusterin or Reg-Ialpha did not sufficient for the diagnosis of latent myocardial ischemia.
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a klusterin $x krev $7 D051152
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lithostatin $x krev $7 D051847
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ischemická choroba srdeční $x diagnóza $7 D017202
650    _2
$a lehké řetězce myosinu $x krev $7 D018994
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a jednofotonová emisní výpočetní tomografie $7 D015899
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lačňák, Bořek $7 xx0062287 $u Department of Laboratory Medicine and Internal Department, Sternberk Hospital
700    1_
$a Karpíšek, Michal $7 xx0107472 $u University of Veterinary and Pharmaceutical Sciences, Brno
700    1_
$a Kamínek, Milan, $d 1965- $7 xx0035550 $u Department of Nuclear Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 150, č. 2 (2006), s. 239-244
910    __
$a ABA008 $b A 1502 $c sign $y 3 $z 0
990    __
$a 20130128 $b ABA008
991    __
$a 20130213090652 $b ABA008
999    __
$a ok $b bmc $g 966328 $s 801867
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2006 $b 150 $c 2 $d 239-244 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20130128

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...